Overview

Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

Status:
Not yet recruiting
Trial end date:
2021-04-05
Target enrollment:
Participant gender:
Summary
A Clinical Trial to evaluate the Pharmacokinetics and safety of CKD-393 0.5/100/1000 mg under fed condition
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical